Afsaneh Lavasanifar Selected Research

Platinum

3/2021	Development of mucoadhesive hydrogels based on polyacrylic acid grafted cellulose nanocrystals for local cisplatin delivery.
8/2014	Polymeric micelles for pH-responsive delivery of cisplatin.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Afsaneh Lavasanifar Research Topics

Disease

67	Neoplasms (Cancer) 03/2024 - 10/2005
20	Breast Neoplasms (Breast Cancer) 01/2023 - 10/2005
15	Melanoma (Melanoma, Malignant) 03/2024 - 03/2007
7	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 01/2018
4	Hemolysis 10/2020 - 02/2002
4	Experimental Melanoma 06/2011 - 09/2008
3	Body Weight (Weight, Body) 01/2020 - 05/2008
3	Hypoxia (Hypoxemia) 12/2018 - 10/2017
2	Triple Negative Breast Neoplasms 01/2023 - 10/2018
2	Neoplasm Metastasis (Metastasis) 01/2022 - 11/2017
2	Drug-Related Side Effects and Adverse Reactions 09/2019 - 01/2018
2	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 05/2016 - 11/2013
2	Ovarian Neoplasms (Ovarian Cancer) 01/2015 - 01/2014
1	Lung Neoplasms (Lung Cancer) 08/2020

Drug/Important Bio-Agent (IBA)

32	MicellesIBA 01/2022 - 02/2002
14	Peptides (Polypeptides)IBA 01/2023 - 03/2007
14	LigandsIBA 01/2022 - 03/2007
13	Small Interfering RNA (siRNA)IBA 12/2019 - 01/2009
10	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2018 - 11/2008
9	Proteins (Proteins, Gene)FDA Link 10/2021 - 09/2008
8	Paclitaxel (Taxol)FDA LinkGeneric 01/2022 - 08/2011
8	Ethylene Oxide (Oxirane)IBA 01/2021 - 10/2005
8	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 10/2018 - 01/2006
7	caprolactoneIBA 01/2021 - 08/2011
6	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 03/2013 - 02/2010
6	stearic acid (magnesium stearate)FDA LinkGeneric 10/2011 - 02/2002
5	PolymersIBA 03/2024 - 02/2010
5	PolyethyleneimineIBA 09/2014 - 02/2010
4	Silybin (Lagosa)IBA 03/2024 - 05/2016
4	Biomarkers (Surrogate Marker)IBA 08/2020 - 01/2017
4	Interleukin-12 (IL 12)IBA 06/2020 - 08/2008
4	cucurbitacin IIBA 01/2017 - 01/2006
4	Liposomes (Liposome)IBA 11/2013 - 05/2013
3	Polynucleotide 5'-Hydroxyl-Kinase (Kinase, Polynucleotide)IBA 01/2022 - 01/2021
3	HydrogelsIBA 01/2022 - 01/2018
3	Hyaluronic Acid (Hyaluronan)IBA 01/2022 - 01/2018
3	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2022 - 01/2021
3	Cisplatin (Platino)FDA LinkGeneric 03/2021 - 10/2017
3	AcidsIBA 03/2021 - 01/2018
3	EstersIBA 10/2020 - 11/2008
3	Ethylene Glycol (Monoethylene Glycol)IBA 01/2020 - 01/2014
3	Cyclosporine (Ciclosporin)FDA LinkGeneric 10/2019 - 10/2006
3	polycaprolactoneIBA 11/2017 - 10/2005
3	AntigensIBA 09/2011 - 09/2008
3	poly(ethylene oxide)-b-poly(alpha-benzyl carboxylate epsilon-caprolactone)IBA 08/2011 - 01/2008
2	Keratin-1IBA 01/2023 - 01/2017
2	GoldIBA 12/2022 - 01/2017
2	ErbB Receptors (EGF Receptor)IBA 01/2022 - 01/2018
2	TensinsIBA 01/2022 - 10/2021
2	Ethanol (Ethyl Alcohol)IBA 10/2021 - 01/2021
2	cremophor ELIBA 10/2021 - 01/2021
2	PlatinumIBA 03/2021 - 08/2014
2	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 10/2017
2	Conditioned Culture MediaIBA 06/2020 - 02/2010
2	Heparin (Liquaemin)FDA LinkGeneric 04/2020 - 01/2020
2	Docetaxel (Taxotere)FDA Link 04/2020 - 02/2020
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2019 - 08/2008
2	polyethylene oxide-polycaprolactone copolymerIBA 11/2019 - 08/2008
2	Phospholipids (Phosphatides)FDA LinkGeneric 11/2019 - 10/2013
2	triphenylphosphoniumIBA 10/2018 - 01/2018
2	OligonucleotidesIBA 06/2018 - 12/2010
2	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 01/2018 - 06/2016
2	Immunosuppressive Agents (Immunosuppressants)IBA 01/2018 - 10/2006
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2017 - 02/2010
2	ArsenicIBA 12/2016 - 08/2014
2	ChitosanIBA 06/2016 - 01/2015
2	alpha-Tocopherol FDA Link 06/2016 - 01/2015
2	LipidsIBA 09/2014 - 02/2010
2	liposomal doxorubicin (Doxil)FDA Link 11/2013 - 05/2013
2	Lysine (L-Lysine)FDA Link 10/2011 - 12/2010
2	VaccinesIBA 09/2011 - 09/2008
2	Cancer VaccinesIBA 09/2011 - 10/2010
2	IntegrinsIBA 06/2011 - 03/2007
2	Polylactic Acid-Polyglycolic Acid CopolymerIBA 04/2010 - 09/2008
2	Lipid AIBA 06/2009 - 09/2008
2	poly(ethylene oxide)-block-poly(N-hexyl stearate) aspartamideIBA 04/2002 - 02/2002
1	Cell Surface ReceptorsIBA 01/2023
1	Radiation-Sensitizing AgentsIBA 12/2022
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2022
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2022
1	Macrophage Colony-Stimulating FactorIBA 01/2022
1	Glucose (Dextrose)FDA LinkGeneric 10/2021
1	Excipients (Suspending Agents)IBA 10/2021
1	A-Form DNA (A-DNA)IBA 10/2021
1	Tumor Suppressor Proteins (Proteins, Tumor Suppressor)IBA 10/2021
1	MucinsIBA 03/2021
1	carbopol 940 (sodium polyacrylate)IBA 03/2021
1	CelluloseIBA 03/2021
1	DNA Repair EnzymesIBA 01/2021
1	alovudineIBA 01/2021
1	AlbuminsIBA 01/2021
1	Therapeutic UsesIBA 01/2021
1	Irinotecan (Camptosar)FDA LinkGeneric 10/2020
1	Complement System Proteins (Complement)IBA 08/2020

Therapy/Procedure

17	Therapeutics 10/2021 - 08/2008
12	Drug Therapy (Chemotherapy) 01/2023 - 12/2010
10	Immunotherapy 01/2022 - 08/2008
3	Intravenous Administration 11/2017 - 01/2016
2	Injections 01/2023 - 01/2022
1	Radiotherapy 12/2022